Table 6. Raw outcomes for change in echocardiography guidelines.
| Author, year | No. TRT | No. placebo | Measure of echocardiography guidelines | TRT group |
Placebo group |
|||
|---|---|---|---|---|---|---|---|---|
| Before (%)* | After (%)* | Before (%)* | After (%)* | |||||
| Mirdamadi et al., 2014 (4) | 25 | 25 | EF | 34.52±7.39 | 37.12±8.23 | 30.76±7.99 | 35.00±7.91 | |
| Iellamo et al., 2010 (7) | 20 | 12 | EF | 32.3±8.1 | 32.1±7.2 | 31.8±7.3 | 31.5±7.7 | |
| Caminiti et al., 2009 (8) | 31 | 33 | EF | 31.5±9.9 | 31.5±9.9 | 33.8±6.5 | 32.8±10.4 | |
| Malkin et al., 2006 (9) | 37 | 39 | EF | 31.8±10.7 | +1.8±13.1 | 33.1±11.8 | +0.95±13.6 | |
*, Data are presented as mean ± SD; †, P<0.05 indicates significance of group difference from baseline. EF, ejection fraction; TRT, testosterone replacement therapy.